GlassScriptPhysician profile
Kerry Lynn Cox
NPI 1992477632
$5,665.74
in general payments reported to CMS, 2019-2025
44 companies · $898 in 2025
The $898 reported for 2025 was more than what 81% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $28.47 · 2022: $719 · 2023: $1,673 · 2024: $2,348 · 2025: $898.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,918.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $846.38 | 2022-2025 | |
| Lilly USA, LLC | $413.86 | 2022-2025 | Mounjaro, Jardiance, Emgality |
| Amgen INC. | $398.63 | 2022-2025 | Repatha, Otezla, Evenity |
| Glaxosmithkline, LLC. | $367.58 | 2022-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Novo Nordisk INC | $325.58 | 2022-2024 | Rybelsus, Ozempic, Wegovy |
| Pfizer INC. | $325.30 | 2023-2025 | |
| Astrazeneca Pharmaceuticals LP | $321.74 | 2021-2025 | Farxiga, Breztri, Airsupra |
| Bayer Healthcare Pharmaceuticals INC. | $265.40 | 2022-2024 | |
| Astellas Pharma US INC | $265.12 | 2023-2025 | Veozah |
| Boehringer Ingelheim Pharmaceuticals, INC. | $232.53 | 2022-2024 | Jardiance, Synjardy |
| Viiv Healthcare Company | $227.73 | 2023-2024 | Apretude |
| Axsome Therapeutics, INC. | $204.05 | 2023-2025 | Sunosi, Auvelity |
| Janssen Pharmaceuticals, INC | $166.41 | 2023-2025 | Spravato |
| Merck Sharp & Dohme LLC | $125.65 | 2022-2025 | Gardasil 9, Vaxneuvance, Capvaxive |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $110.80 | 2025 | Caplyta |
Show all 44 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lucid Diagnostics INC. | $99.74 | 2022-2023 | |
| Exact Sciences Corporation | $98.28 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Gilead Sciences, INC. | $69.73 | 2022-2023 | |
| Sanofi-Aventis U.S. LLC | $67.72 | 2024-2025 | |
| Dynavax Technologies Corporation | $58.64 | 2023-2025 | Heplisav-B |
| Impel Pharmaceuticals INC. | $52.11 | 2023 | Trudhesa |
| Corcept Therapeutics | $52.06 | 2024 | Korlym |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.22 | 2024-2025 | Xifaxan, Trulance |
| Mylan Specialty L.P. | $41.87 | 2023 | Yupelri |
| Inspire Medical Systems, INC. | $39.10 | 2024 | Inspire |
| Organon LLC | $37.26 | 2023-2025 | Nexplanon |
| Idorsia Pharmaceuticals US INC | $35.91 | 2022-2023 | Quviviq |
| Lundbeck LLC | $35.80 | 2024 | Vyepti |
| Halozyme INC | $31.88 | 2023 | |
| Hologic Sales and Service, LLC | $31.33 | 2023 | Thinprep 2000 Processor, Aptima |
| Corium, LLC | $30.73 | 2024 | Azstarys |
| Tris Pharma INC | $24.32 | 2024 | Dyanavel Xr |
| Seqirus USA INC | $23.11 | 2025 | Flucelvax, Fluad |
| Xeris Pharmaceuticals, INC. | $21.42 | 2023 | Keveyis |
| Exeltis, USA INC. | $20.68 | 2024 | Slynd |
| Cranial Technologies, INC | $19.86 | 2025 | Doc Band |
| Ultragenyx Pharmaceutical INC. | $19.18 | 2022 | |
| Dexcom, INC. | $18.95 | 2025 | Dexcom G6 Transmitter |
| Nevro Corp. | $18.31 | 2022 | |
| Harmony Biosciences LLC | $18.11 | 2024 | |
| Biohaven Pharmaceuticals, INC. | $16.53 | 2021 | |
| Collegium Pharmaceutical, INC. | $13.50 | 2022 | |
| Qorumpartners | $12.60 | 2022 | |
| Phathom Pharmaceuticals, INC. | $12.03 | 2025 | Voquezna |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kerry Cox listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.